Literature DB >> 20536565

Once a killer, always a killer: from cytotoxic T cell to memory cell.

Leo Lefrançois1, Joshua J Obar.   

Abstract

The control of the differentiation pathways followed by responding CD8(+) T cells to produce protective memory cells has been intensely studied. Recent developments have identified heterogeneity at the effector cytotoxic T-lymphocyte level within which a bona fide memory cell precursor has emerged. The challenge now is to identify the cellular and molecular factors that control this developmental pathway. This review considers aspects of the regulation of the induction of effectors, the transition of effectors to memory cells, and the dynamics of the memory population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536565      PMCID: PMC2989239          DOI: 10.1111/j.0105-2896.2010.00895.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  138 in total

1.  Cutting edge: sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease.

Authors:  J E Buhlmann; M Gonzalez; B Ginther; A Panoskaltsis-Mortari; B R Blazar; D L Greiner; A A Rossini; R Flavell; R J Noelle
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

2.  Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}.

Authors:  Mark P Rubinstein; Marek Kovar; Jared F Purton; Jae-Ho Cho; Onur Boyman; Charles D Surh; Jonathan Sprent
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

3.  Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin.

Authors:  Andrew M Intlekofer; Naofumi Takemoto; E John Wherry; Sarah A Longworth; John T Northrup; Vikram R Palanivel; Alan C Mullen; Christopher R Gasink; Susan M Kaech; Joseph D Miller; Laurent Gapin; Kenneth Ryan; Andreas P Russ; Tullia Lindsten; Jordan S Orange; Ananda W Goldrath; Rafi Ahmed; Steven L Reiner
Journal:  Nat Immunol       Date:  2005-11-06       Impact factor: 25.606

Review 4.  Triggering TLR signaling in vaccination.

Authors:  David van Duin; Ruslan Medzhitov; Albert C Shaw
Journal:  Trends Immunol       Date:  2005-11-23       Impact factor: 16.687

5.  Cutting edge: latecomer CD8 T cells are imprinted with a unique differentiation program.

Authors:  Warren N D'Souza; Stephen M Hedrick
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

6.  CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion.

Authors:  Peter Aichele; Heike Unsoeld; Marie Koschella; Oliver Schweier; Ulrich Kalinke; Smiljka Vucikuja
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

7.  Selective stimulation of T cell subsets with antibody-cytokine immune complexes.

Authors:  Onur Boyman; Marek Kovar; Mark P Rubinstein; Charles D Surh; Jonathan Sprent
Journal:  Science       Date:  2006-02-16       Impact factor: 47.728

8.  Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

Authors:  Matthew A Williams; Aaron J Tyznik; Michael J Bevan
Journal:  Nature       Date:  2006-06-15       Impact factor: 49.962

9.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection.

Authors:  Ganesh A Kolumam; Sunil Thomas; Lucas J Thompson; Jonathan Sprent; Kaja Murali-Krishna
Journal:  J Exp Med       Date:  2005-08-29       Impact factor: 14.307

10.  CD4+ T cells that enter the draining lymph nodes after antigen injection participate in the primary response and become central-memory cells.

Authors:  Drew M Catron; Lori K Rusch; Jason Hataye; Andrea A Itano; Marc K Jenkins
Journal:  J Exp Med       Date:  2006-03-27       Impact factor: 14.307

View more
  52 in total

1.  Phenotypic changes to the endogenous antigen-specific CD8+ T cell response correlates with the development and resolution of allergic airway disease.

Authors:  Jeffrey T McNamara; Craig M Schramm; Anurag Singh; Eric R Secor; Linda A Guernsey; Leo Lefrançois; Roger S Thrall
Journal:  Am J Pathol       Date:  2012-03-24       Impact factor: 4.307

Review 2.  Early events governing memory CD8+ T-cell differentiation.

Authors:  Joshua J Obar; Leo Lefrançois
Journal:  Int Immunol       Date:  2010-05-26       Impact factor: 4.823

3.  Changes in leukocyte populations of cows with milk fever or displaced abomasum after calving.

Authors:  Hiromichi Ohtsuka; Shigeo Fukuda; Katsunori Kudo; Michiko Tomioka; Masateru Koiwa; Kayoko Kimura
Journal:  Can J Vet Res       Date:  2013-07       Impact factor: 1.310

4.  Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.

Authors:  Charles S Rosenberg; Weibo Zhang; Juan M Bustamante; Rick L Tarleton
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

5.  Synthetic vaccines: Immunity without harm.

Authors:  Abhinav P Acharya; Niren Murthy
Journal:  Nat Mater       Date:  2011-03       Impact factor: 43.841

6.  Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8+ T Cells in a Diameter-Dependent Manner.

Authors:  Bala V K Karuturi; Shailendra B Tallapaka; Pravin Yeapuri; Stephen M Curran; Sam D Sanderson; Joseph A Vetro
Journal:  Mol Pharm       Date:  2017-04-03       Impact factor: 4.939

Review 7.  Regional and mucosal memory T cells.

Authors:  Brian S Sheridan; Leo Lefrançois
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

Review 8.  Improving T cell responses to modified peptides in tumor vaccines.

Authors:  Jonathan D Buhrman; Jill E Slansky
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

9.  Dendritic cells tolerized with adenosine A₂AR agonist attenuate acute kidney injury.

Authors:  Li Li; Liping Huang; Hong Ye; Steven P Song; Amandeep Bajwa; Sang Ju Lee; Emily K Moser; Katarzyna Jaworska; Gilbert R Kinsey; Yuan J Day; Joel Linden; Peter I Lobo; Diane L Rosin; Mark D Okusa
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

10.  High viral burden restricts short-lived effector cell number at late times postinfection through increased natural regulatory T cell expansion.

Authors:  Samuel Amoah; Beth C Holbrook; Rama D Yammani; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2013-04-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.